Search clinical trials for: ALMB-0166

Total 240 results

University Hospitals Cleveland Medical Center

Completed

Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa

Lymphatic Filariasis

Papua New Guinea
Jennifer Keiser
Public Health Laboratory Ivo de Carneri

Recruiting

Efficacy and Safety of MOX/ALB Co-administration in SAC (Moxiped)

Hookworm Infections | Ascariasis | Trichuriasis

Tanzania
Genuine Research Center, Egypt
Hikma Pharmaceuticals LLC

Completed

Bioequivalence Study of Budesonide From Ekmasonid 9 mg Extended Release FCT (Hikma Pharma, Egypt) Versus Uceris 9 mg Extended Release Tablets (Man. for: Salix Pharm., a Division of Valeant Pharm. LLC, USA, by: Cosmo S.P.A., Italy by License of Cosmo Tech. Ltd., Ireland, Product of France)

Healthy

Egypt
Sidney Kimmel Comprehensive Cancer Center at Johns...
Bristol-Myers Squibb

Terminated

Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma

Glioblastoma | Glioblastoma Multiforme

United States
Indian Council of Medical Research

Completed

Alternate Chemotherapy Regimens for the Clearance of W.Bancrofti Infection

Filarial; Infestation

India
AbbVie
Boehringer Ingelheim

Completed

BI 655066/ABBV-066 (Risankizumab) Compared to Active Comparator (Adalimumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

Psoriasis
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Withdrawn

Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's Lymphoma

Lymphoma

United States
AbbVie

Completed

A Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

Crohn's Disease | Ulcerative Colitis (UC)

United States, Germany, Israel
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Poniard Pharmaceuticals

Completed

Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Rambam Health Care Campus

Terminated

Pain Treatment After Total Knee Replacement - Continuous Epidural Versus Intravenous Patient Controlled Analgesia With Morphine

Pain, Postoperative | Osteoarthritis

Israel
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Aphaia Pharma US LLC
NovaClin Medical Research Center S.R.L; ACC GmbH Analytical Clinical Concepts; SC Bioclinica... and other collaborators

Completed

Pharmacodynamics and Pharmacokinetics of Different Glucose Bead Formulations in Obese Healthy Subjects

Obese

Romania
Aptevo Therapeutics

Completed

A Study of TRU-016 in Combination With Rituximab and Bendamustine in Subjects With Relapsed Indolent Lymphoma

B-cell Small Lymphocytic Lymphoma Recurrent

United States
MediciNova

Active, not recruiting

Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS

Pneumonia, Viral

United States
MediciNova

Completed

Relative Bioavailability of MN-166 (Ibudilast) in Extended Release Tablet vs. Intermediate-release Capsule in Healthy Volunteers

Healthy Volunteers

United States
Cynthia McEvoy
University of Florida; University of California, San Francisco; Thrasher Research... and other collaborators

Completed

Steroids and Surfactant in Extremely Low Gestation Age Infants Dose Escalation Trial (SASSIE)

Bronchopulmonary Dysplasia (BPD)

United States
MediciNova

Recruiting

Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS (COMBAT-ALS)

Amyotrophic Lateral Sclerosis

United States, Canada
Batman Training and Research Hospital

Completed

The Effect of Turmeric on New Onset Primary Dysmenorrhea

Primary Dysmenorrhea

Turkey
MediciNova
Massachusetts General Hospital; South Shore Neurologic Associates

Completed

A Biomarker Study to Evaluate MN-166 (Ibudilast) in Subjects With Amyotrophic Literal Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

United States
MediciNova
National Institute of Neurological Disorders and Stroke (NINDS); National Institutes... and other collaborators

Completed

Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis

Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive

United States
MediciNova

Completed

Study of MN-166 (Ibudilast) Extended Release Tablet Formulations Compared With Capsules in Healthy Volunteers

Healthy Volunteers

United States
Sohag University

Enrolling by invitation

Comparison Between Early-onset and Late-onset Patients With Systemic Lupus Erythematosus.

Systemic Lupus Erythematosus

Egypt
AbbVie

Completed

Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy

Psoriasis

United States, Canada, Germany, Israel, Poland
University Health Network, Toronto

Recruiting

RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine (RECLAIM)

Long COVID | Post Acute Sequelae of COVID-19 | Post COVID Condition

Canada
University of California, Los Angeles
National Institute on Alcohol Abuse and Alcoholism (NIAAA); MediciNova

Completed

Ibudilast for the Treatment of Alcohol Use Disorder

Alcohol Use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); MediciNova

Completed

Effects of Ibudilast on Oxycodone Self-administration in Opioid Abusers

Opioid Dependence | Opioid Abuse

United States
University of California, Los Angeles
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Development of Ibudilast for Alcohol Use Disorder

Alcohol Use Disorders

United States
AbbVie

Completed

A Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis

Psoriasis

Brazil
Taipei Veterans General Hospital, Taiwan

Unknown

Peptic Ulcer Disease in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Proton Pump Inhibitor

Peptic Ulcer | Ulcer Complications

Taiwan
MediciNova

Active, not recruiting

Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma

Glioblastoma | GBM | Recurrent Glioblastoma | Newly Diagnosed Glioblastoma

United States
AbbVie
Boehringer Ingelheim

Completed

Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis

Psoriasis

United States, Germany, United Kingdom
University of Pennsylvania

Recruiting

Ibudilast for Treating Alcohol Use Disorder (Ibudilast)

Alcoholism | Alcohol Use Disorder (AUD)

United States
CHU de Quebec-Universite Laval
Canadian Institutes of Health Research (CIHR); Biovalorem

Active, not recruiting

Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma

Pancreatic Cancer | Metastatic Cancer | Pancreatic Ductal Adenocarcinoma | Pancreas Cancer

Canada
Thomas Jefferson University

Completed

The Effects of Moviprep With Simethicone on Colonic Bubbles

Bubbles in Colon at Time of Colonoscopy

United States
Postgraduate Institute of Medical Education and...

Recruiting

Amphotericin Versus Posaconazole for Pulmonary Mucormycosis

Mucormycosis; Pulmonary (Etiology)

India
Washington University School of Medicine

Completed

Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis (DOLF-Indo)

Lymphatic Filariasis | Soil Transmitted Helminth Infections

Indonesia
AbbVie (prior sponsor, Abbott)

Completed

Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact (DAPHNE)

Advanced Idiopathic Parkinson's Disease
National Cancer Institute (NCI)

Terminated

Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma

Mesothelioma

United States
AbbVie
Boehringer Ingelheim

Completed

This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic Arthritis

Psoriasis

Germany

3

Subscribe